Since 2007, ISF has been a beacon of hope, leading collaborative efforts with medical institutions. Our innovative research and pioneering treatments have saved thousands of lives and improved the quality of life for young cancer patients worldwide. 

Today, ISF remains steadfast in its dedication to eradicating the devastating impact of rare pediatric cancer, all while honoring the legacy of Isabella Santos, a courageous cancer warrior who lost her fight to neuroblastoma in 2012.